Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

india-pharmacy

  1. Home>
  2. News>
  3. india-pharmacy>
  4. Page 4

How to Import Indian Generic Medicines: A 2026 Buyer’s Regulatory Guide

  • Post published:August 18, 2026
  • Post category:Knowledge

Importing generic medicines from India can deliver substantial savings, but the regulatory landscape is complex and varies significantly by destination country. This guide walks buyers through the key regulatory requirements,…

Continue Reading How to Import Indian Generic Medicines: A 2026 Buyer’s Regulatory Guide

India Pharma 2030 Export Target Cut to $90 Billion Amid Tariff and Shipping Crisis

  • Post published:August 17, 2026
  • Post category:News

India's pharmaceutical industry is on track to miss its ambitious 2030 export target of $130 billion, with sector leaders now projecting a revised figure of approximately $90 billion — a…

Continue Reading India Pharma 2030 Export Target Cut to $90 Billion Amid Tariff and Shipping Crisis

How to Verify Quality of Indian Generic Medicines: A Buyer’s Checklist

  • Post published:August 16, 2026
  • Post category:Knowledge

Buying generic medicines from India can save you a significant amount of money, but quality verification is essential. This guide walks you through the key checks every buyer — whether…

Continue Reading How to Verify Quality of Indian Generic Medicines: A Buyer’s Checklist

CDSCO Digital Drug Platform: End-to-End Regulatory System in 18 Months

  • Post published:August 15, 2026
  • Post category:News

India’s drug regulator is building a fully digital, end-to-end regulatory platform — and the first phase is expected to go live within 18 months. The announcement, made by Drugs Controller…

Continue Reading CDSCO Digital Drug Platform: End-to-End Regulatory System in 18 Months
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 19
  • Go to the next page

Recent Posts

  • CDSCO Mandates Pharma Companies to Maintain Adverse Event Reporting Systems
    September 1, 2026/
    0 Comments
  • India Pushes for Pharma Market Access in Argentina and Brazil
    August 31, 2026/
    0 Comments
  • India’s Pharma Ambitions Meet Regulatory Capacity: What Buyers Should Know
    August 30, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • CDSCO Mandates Pharma Companies to Maintain Adverse Event Reporting Systems
  • India Pushes for Pharma Market Access in Argentina and Brazil
  • India’s Pharma Ambitions Meet Regulatory Capacity: What Buyers Should Know
  • CBN and PHARMEXCIL Sign MoU on Controlled Substances Exports
  • Understanding India’s Drug Safety Framework: A 2026 Buyer’s Guide

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve